NRx Pharmaceuticals, Inc.
NRXP
$3.87
-$0.46-10.62%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.71M | 7.80M | 7.18M | 2.91M | 5.55M |
| Total Receivables | 181.00K | 161.00K | 3.33M | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 240.00K | 590.00K | 1.44M | 919.00K | 1.02M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 227.00K | 344.00K | -- | 761.00K | 693.00K |
| Total Current Assets | 7.36M | 8.89M | 11.95M | 4.59M | 7.26M |
|
|
|||||
| Total Current Assets | 7.36M | 8.89M | 11.95M | 4.59M | 7.26M |
| Net Property, Plant & Equipment | 1.20M | 696.00K | 419.00K | 8.00K | -- |
| Long-term Investments | 1.79M | 1.79M | 610.00K | -- | -- |
| Goodwill | 1.79M | 1.79M | 610.00K | -- | -- |
| Total Other Intangibles | 879.00K | 925.00K | 1.78M | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 276.00K | 253.00K | 243.00K | 240.00K | 334.00K |
| Total Assets | 11.90M | 12.96M | 15.00M | 4.84M | 7.59M |
|
|
|||||
| Total Accounts Payable | 4.40M | 4.27M | 4.26M | 3.63M | 4.31M |
| Total Accrued Expenses | 5.42M | 5.62M | 5.47M | 5.99M | 5.48M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 391.00K | 316.00K | 10.10M | 9.85M | 8.40M |
| Total Finance Division Other Current Liabilities | 14.96M | 18.37M | 20.77M | 20.98M | 14.57M |
| Total Other Current Liabilities | 14.96M | 18.37M | 20.77M | 20.98M | 14.57M |
| Total Current Liabilities | 25.18M | 28.58M | 40.59M | 40.45M | 32.75M |
|
|
|||||
| Total Current Liabilities | 25.18M | 28.58M | 40.59M | 40.45M | 32.75M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 543.00K | 315.00K | 158.00K | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 25.72M | 28.89M | 40.75M | 40.45M | 32.75M |
|
|
|||||
| Common Stock & APIC | 294.51M | 290.96M | 281.50M | 265.75M | 258.62M |
| Retained Earnings | -308.33M | -306.90M | -307.26M | -301.37M | -283.79M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -13.82M | -15.94M | -25.76M | -35.62M | -25.16M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -13.82M | -15.94M | -25.76M | -35.62M | -25.16M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -13.82M | -15.94M | -25.76M | -35.62M | -25.16M |
|
|
|||||